Written by FormBlends Editorial Research · Checked against primary sources by FormBlends Medical Team
Custom header image for Glp1 Eligibility Quiz What Questions Will My Doctor Ask, GLP-1 Weight Loss, and better treatment decision-making.In This Article
If you're thinking about starting GLP-1 medication, you probably have some nerves about the screening process. What will they ask? What if you give the wrong answer? Knowing the GLP-1 eligibility quiz questions ahead of time can take the anxiety out of the process and help you feel prepared.
If you're thinking about starting GLP-1 medication, you probably have some nerves about the screening process. What will they ask? What if you give the wrong answer? Knowing the GLP-1 eligibility quiz questions ahead of time can take the anxiety out of the process and help you feel prepared.
Key Takeaways:
- Questions About Your Height, Weight, and BMI
- Questions About Your Medical History
- Questions About Your Current Medications
- Questions About Your Weight Loss History and Goals
- Questions About Lifestyle and Readiness
The truth is there are no trick questions. Providers are looking for basic health information to determine whether GLP-1 medication is safe and appropriate for you. This guide previews every category of question you're likely to encounter so you can walk in with confidence.
Questions About Your Height, Weight, and BMI
Every GLP-1 eligibility screening starts with the basics. Your provider needs to know your current body measurements to calculate your BMI and determine if you meet the prescribing thresholds.
Expect questions like:
What is your current height?
What is your current weight?
What is your goal weight?
What was your highest adult weight?
Have you gained or lost significant weight recently?
Your BMI is calculated from your height and weight. A BMI of 30 or higher qualifies you based on weight alone. A BMI of 27 to 29.9 may qualify you if you also have a weight-related health condition. You can to get a head start.
Don't stress about the exact numbers. Providers understand that weight fluctuates. They're looking at the overall picture, not judging you for a specific number on a specific day. Be honest, because accurate measurements lead to the right dose and the best results.
Questions About Your Medical History
"The conversation about obesity needs to shift from willpower to biology. These medications work because obesity is a neuroendocrine disease, not a character flaw.") Dr. Fatima Cody Stanford, MD, MPH, Massachusetts General Hospital
GLP-1 Weight Loss Results by Medication. Based on published STEP and SURMOUNT trial data.
View data table
Bar chart showing glp-1 weight loss results by medication: Tirzepatide (22), Semaglutide (15), Liraglutide (8), Retatrutide (24)
Category
Mean Body Weight Loss (%)
Detail
Tirzepatide
22
~22% body weight at 72 wks
Semaglutide
15
~15% body weight at 68 wks
Liraglutide
8
~8% body weight at 56 wks
Retatrutide
24
~24% in Phase 2 trial
This is the most detailed part of the screening. Your provider needs a clear picture of your health to prescribe safely. Think of this as a conversation, not an interrogation.
Common medical history questions include:
Have you ever been diagnosed with type 2 diabetes or prediabetes?
Do you have high blood pressure?
Have you been diagnosed with high cholesterol or high triglycerides?
Do you have sleep apnea?
Have you been diagnosed with PCOS?
Do you have a history of pancreatitis?
Have you or anyone in your family had thyroid cancer, specifically medullary thyroid carcinoma?
Do you have any history of eating disorders?
Have you had bariatric surgery?
Some of these questions identify qualifying conditions that support your eligibility. Others screen for contraindications that could make GLP-1 medication unsafe. For example, a personal or family history of medullary thyroid carcinoma is a contraindication for GLP-1 use.
If you have been diagnosed with conditions you're unsure about, it's fine to say so. Your provider can look into your records or order additional tests. The goal is to gather information, not to catch you off guard. Learn more about which .
Patient Perspective:"I was surprised I qualified (I didn't think of myself as 'obese enough' for medication. But my BMI was 32 with high blood pressure, and my provider explained that's exactly who these medications were designed for.") Nicole F., 42, FormBlends patient (name changed for privacy)
Free Download: GLP-1 Eligibility Self-Assessment Checklist
Want to organize all your health details before your screening? This checklist covers every question category so you can walk in prepared and confident. Get yours free -- we will email it to you instantly.
[Download Your Free Checklist]
Questions About Your Current Medications
Your provider needs to know what you're currently taking to avoid harmful interactions and adjust your treatment plan accordingly.
Check your GLP-1 eligibility
Use our free BMI Calculator to see if you may qualify for provider-reviewed GLP-1 therapy.
All prescription medications you take (name, dose, frequency)
Over-the-counter medications you use regularly
Supplements, vitamins, and herbal products
Any recent medication changes
GLP-1 medications can interact with certain drugs, especially insulin, sulfonylureas, and oral diabetes medications. This doesn't automatically disqualify you. It just means your provider may need to adjust your other medications when you start GLP-1 treatment.
A helpful tip: make a list of everything you take before your screening. Include the exact dose and how often you take it. This saves time and ensures nothing gets missed. If you use the , you can log your medications there and have them ready to share during your consultation.
Blood thinners, thyroid medications, and psychiatric medications are also worth mentioning. Your provider will know how to account for any interactions and build a safe treatment plan around your full medication profile.
Questions About Your Weight Loss History and Goals
Providers want to understand your relationship with weight management. This isn't about judging past failures. It's about understanding what you have already tried so they can recommend the most effective path forward.
You may be asked:
What diets or weight loss programs have you tried?
Have you used weight loss medications before? If so, which ones?
How long have you been trying to lose weight?
What is your primary motivation for seeking treatment?
Do you have a target weight or size in mind?
Are you currently following an exercise routine?
Most GLP-1 prescribing guidelines recommend that patients have attempted diet and exercise before starting medication. This doesn't mean you need to present a detailed log. Simply being honest about your experience is enough.
Your goals matter too. Providers use them to set realistic expectations and track your progress. A good provider will help you on a realistic timeline rather than promising overnight transformation.
Questions About Lifestyle and Readiness
The final category of questions focuses on whether you're ready to commit to the full treatment process. GLP-1 medication works best as part of a thorough approach that includes nutrition, movement, and consistent follow-up.
Expect questions like:
Are you comfortable with self-administered injections?
Can you commit to regular follow-up appointments?
Are you willing to make dietary changes alongside medication?
Do you have support at home for your weight loss goals?
Are you currently pregnant, breastfeeding, or planning to become pregnant?
These questions help your provider gauge how well the treatment fits your current life. If you aren't comfortable with injections, they can discuss alternatives or teach you proper technique. If you're planning a pregnancy, they will explain the timing considerations.
No answer here disqualifies you automatically. The questions are designed to tailor your treatment plan, not to create barriers. Being open about your concerns leads to better support from your provider.
Frequently Asked Questions
What is the most important question in the GLP-1 eligibility quiz?
The BMI calculation is the primary qualifying factor. If your BMI is 30 or above, you meet the weight threshold. If it's between 27 and 29.9, your provider will look at whether you have a qualifying health condition. Everything else helps your provider personalize your treatment.
Can I fail the GLP-1 eligibility quiz?
There's no pass or fail. The quiz identifies whether GLP-1 medication is safe and appropriate for you. If you don't qualify right now, your provider can explain why and discuss alternative options or steps you can take to revisit eligibility later.
Should I bring lab results to my GLP-1 consultation?
If you have recent lab work from the past 6 to 12 months, bring it. Useful labs include a metabolic panel, lipid panel, A1C, and thyroid function tests. If you don't have recent labs, your provider can order them as part of the evaluation.
How long does the GLP-1 eligibility quiz take?
The takes about two minutes. It covers the key screening questions and gives you an immediate preliminary result. The full consultation with a provider typically takes 15 to 20 minutes after that.
Do I need to prepare anything before taking the quiz?
Knowing your current height, weight, medication list, and health conditions will help you complete the quiz quickly and accurately. The can help you organize this information ahead of time.
Your Personalized Plan Is Waiting
No two patients are the same, and your protocol shouldn't be either. FormBlends providers create customized treatment plans based on your health profile, goals, and preferences.
Medical References
Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2). Lancet. 2021;397(10278):971-984. [PubMed | ClinicalTrials.gov | DOI]
Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3). JAMA. 2021;325(14):1403-1413. [PubMed | ClinicalTrials.gov | DOI]
Garvey WT, Batterham RL, Bhatt DL, et al. Two-year effects of semaglutide in adults with overweight or obesity (STEP 5). Nat Med. 2022;28(10):2083-2091. [PubMed | ClinicalTrials.gov | DOI]
Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2). Lancet. 2023;402(10402):613-626. [PubMed | ClinicalTrials.gov | DOI]
Wadden TA, Chao AM, Engel S, et al. Tirzepatide with intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3). Nat Med. 2024. [PubMed | ClinicalTrials.gov | DOI]
Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4). JAMA. 2024;331(1):38-48. [PubMed | ClinicalTrials.gov | DOI]
Sources &. References
Wilding JPH, Batterham RL, Calanna S, et al. Once-Weekly Semaglutide in Adults with Overweight or Obesity. N Engl J Med. 2021;384(11):989-1002. Doi:10.1056/NEJMoa2032183
Davies M, Færch L, Jeppesen OK, et al. Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2 (Davies et al., Lancet, 2021)). Lancet. 2021;397(10278):971-984. Doi:10.1016/S0140-6736(21)00213-0
Wadden TA, Bailey TS, Billings LK, et al. Effect of Subcutaneous Semaglutide vs Placebo as an Adjunct to Intensive Behavioral Therapy on Body Weight in Adults With Overweight or Obesity (STEP 3 (Wadden et al., JAMA, 2021)). JAMA. 2021;325(14):1403-1413. Doi:10.1001/jama.2021.1831
Garvey WT, Batterham RL, Bhatt DL, et al. Two-Year Effects of Semaglutide in Adults with Overweight or Obesity (STEP 5 (Garvey et al., Nat Med, 2022)). Nat Med. 2022;28:2083-2091. Doi:10.1038/s41591-022-02026-4
Lincoff AM, Brown-Frandsen K, Colhoun HM, et al. Semaglutide and Cardiovascular Outcomes in Obesity without Diabetes. N Engl J Med. 2023;389(24):2221-2232. Doi:10.1056/NEJMoa2307563
Jastreboff AM, Aronne LJ, Ahmad NN, et al. Tirzepatide Once Weekly for the Treatment of Obesity. N Engl J Med. 2022;387(3):205-216. Doi:10.1056/NEJMoa2206038
Garvey WT, Frias JP, Jastreboff AM, et al. Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2[4] (Garvey et al., Lancet, 2023)). Lancet. 2023;402(10402):613-626. Doi:10.1016/S0140-6736(23)01200-X
Wadden TA, Chao AM, Engel S, et al. Tirzepatide after intensive lifestyle intervention in adults with overweight or obesity (SURMOUNT-3[5] (Wadden et al., Nat Med, 2023)). Nat Med. 2023. Doi:10.1038/s41591-023-02597-w
Aronne LJ, Sattar N, Horn DB, et al. Continued Treatment With Tirzepatide for Maintenance of Weight Reduction in Adults With Obesity (SURMOUNT-4[6] (Aronne et al., JAMA, 2024)). JAMA. 2024;331(1):38-48. Doi:10.1001/jama.2023.24945
Malhotra A, Grunstein RR, Fietze I, et al. Tirzepatide for the Treatment of Obstructive Sleep Apnea and Obesity. N Engl J Med. 2024;391:1193-1205. Doi:10.1056/NEJMoa2404881
Stierman B, Afful J, Carroll MD, et al. National Health and Nutrition Examination Survey 2017-March 2020 Prepandemic Data Files. NCHS Data Brief. No. 492. CDC/NCHS. 2023.
Sumithran P, Prendergast LA, Delbridge E, et al. Long-Term Persistence of Hormonal Adaptations to Weight Loss. N Engl J Med. 2011;365(17):1597-1604. Doi:10.1056/NEJMoa1105816
The information in this article is intended for educational use only and shouldn't be considered medical advice. Consult a qualified healthcare provider before making any changes to your medication or supplement regimen. FormBlends helps with connections with licensed providers for personalized medical guidance.
Last updated: 2026-03-24
Talk to a licensed provider
Start your free assessment. A licensed provider reviews every request before anything is prescribed, and not everyone qualifies.
Check the current prescribing information, regulatory status, and trial source before treating an investigational or newly approved medication as interchangeable with an established therapy.
Check before ordering
Regulatory status, labels, trial records, and sponsor updates can change quickly for obesity-drug pipeline pages. This snapshot is designed to make verification easier, not to replace checking the official source before making a medical or purchase decision. Last page review: 2026-04-01.
FormBlends does not claim an individual clinician byline unless a named reviewer is available. For this page, the editorial team checks medical and regulatory claims against primary sources, clinical trials, public datasets, and regulator guidance.
For Glp1 Eligibility Quiz What Questions Will My Doctor Ask, FormBlends checks the page topic against primary trials, systematic reviews, guidelines, and current PubMed-indexed literature where available. These citations are context, not medical advice, proof of eligibility, or a claim that every study applies to every patient.
Use this page to decide if a provider review is the right next step
Direct answer
Glp1 Eligibility Quiz What Questions Will My Doctor Ask research is most useful when it helps you compare eligibility, expected results, side effects, cost, and the supervision needed before treatment.
If you are thinking about starting GLP-1 medication, you probably have some nerves about the screening process. What will they ask. "Glp1 Eligibility Quiz What Questions Will My Doctor Ask" earns its keep when it helps a reader move from a broad question to a cleaner next step. This is a GLP-1 treatment guide where medication choice, dosing, side effects, monitoring, and insurance rules can change the decision, and the reader usually needs help with patient education and clinical context. Pay extra attention to the main claim, safety boundary, and next practical step and related tags such as GLP-1, weight management, glp1. Because this article has 8 major sections, scan the headings first and then use the FAQ or summary sections to pressure-test the answer.
Confirm whether the page is discussing an FDA-approved use, a compounded option, or research-only context.
Ask a licensed clinician how the evidence applies to your health history, medications, labs, and side-effect risk.
Check the latest label, trial update, pharmacy policy, or state rule when the article touches medication access.
Original tools and data
Use the FormBlends research stack
These assets are built to be useful beyond a single article: shareable data pages, calculators, provider comparisons, and safety checks that give Google and readers something original to crawl.
Practical 2026 note for Glp1 Eligibility Quiz What Questions Will My Doctor Ask
Glp1 Eligibility Quiz What Questions Will My Doctor Ask now carries extra 2026 context around semaglutide, tirzepatide, retatrutide, glp1, eligibility, quiz, because those are the subtopics readers tend to compare before they trust a medical or wellness recommendation.
Instead of adding filler, this page keeps the named treatment terms, practical verification points, and next-step questions close to glp1 eligibility quiz what questions will my doctor ask.
Readers should use the section to check current eligibility, pharmacy or provider policies, and safety questions with a licensed professional before acting.
Custom 2026 image for Glp1 Eligibility Quiz What Questions Will My Doctor Ask, glp-1 weight loss, and better treatment decision-making.
Image description: Unique image for this page covering Glp1 Eligibility Quiz What Questions Will My Doctor Ask, glp-1 weight loss, safety, cost, provider selection, and patient decision-making.
Medical Disclaimer: This content is for informational purposes only and does not constitute medical advice. Always consult a qualified healthcare provider before starting, stopping, or changing any medication or treatment. FormBlends articles are source-checked against medical and regulatory references, but they are not a substitute for a personal medical consultation.
Written by FormBlends Editorial Research
Prepared by FormBlends Editorial Research. Claims are checked against primary regulatory, trial, label, and public-health sources where available. Reviewed by FormBlends Medical Team for medical accuracy, sourcing, and patient-safety framing.
Ready to get started?
Provider-reviewed GLP-1 and peptide therapy, delivered to your door.
